A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors

Table 1

Gene set enrichment analysis of CKS1B.

Gene set name	NES	value	FDR -val
KEGG_DRUG_METABOLISM_CYTOCHROME_P450	-2.414	0.002	0.012
KEGG_RETINOL_METABOLISM	-2.368	0.002	0.012
KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	-2.317	0.002	0.012
KEGG_STEROID_HORMONE_BIOSYNTHESIS	-2.289	0.002	0.012
KEGG_ASTHMA	-2.267	0.002	0.012
KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	-2.252	0.002	0.012
REACTOME_GLUCURONIDATION	-2.225	0.002	0.012
REACTOME_PD_1_SIGNALING	-2.222	0.002	0.012
KEGG_ALLOGRAFT_REJECTION	-2.209	0.002	0.012
WP_PREGNANE_X_RECEPTOR_PATHWAY	-2.198	0.002	0.012
REACTOME_G2_M_CHECKPOINTS	2.807	0.003	0.012
REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION	2.819	0.003	0.012
REACTOME_MITOTIC_SPINDLE_CHECKPOINT	2.85	0.003	0.012
REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION	2.857	0.003	0.012
REACTOME_M_PHASE	2.901	0.003	0.012
REACTOME_MITOTIC_PROMETAPHASE	2.914	0.003	0.012
WP_CELL_CYCLE	2.951	0.003	0.012
KEGG_CELL_CYCLE	2.976	0.003	0.012
WP_RETINOBLASTOMA_GENE_IN_CANCER	2.979	0.003	0.012
REACTOME_CELL_CYCLE_CHECKPOINTS	3.11	0.003	0.012